Delivery Order SPE2DB20D3505-SPE2DB25FYCHE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,644.69 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (30-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitive award utilizes firm fixed-price pricing with no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for NEXIUM DR 20 mg capsules (90-count) valued at $1,299.08 under a firm fixed-price contract type. The award, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-competitive delivery against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the...
- The Defense Logistics Agency awarded a delivery order valued at $5,369.77 to AmerisourceBergen Drug Corp for 90-count bottles of Nexium DR 40 mg capsules. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexium DR 40 mg capsules (90-count) valued at $9,382.42. This firm fixed price, non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item delivery under the company's larger pharmaceutical supply...
- This delivery order, awarded on July 31, 2025, represents a $1,125.04 firm fixed-price procurement of NEXIUM DR 40 mg capsules (90-count units) through the Defense Logistics Agency's Medical Supply Chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received this non-set-aside award with an ultimate completion date of August 1, 2025. The contract is a child award under AmerisourceBergen's significantly larger Indefinite Delivery Contract (IDC) designated SPE2DX...
- The Defense Logistics Agency awarded a delivery order valued at $8,400.65 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is performing the work at...
- The Defense Logistics Agency awarded a delivery order valued at $1,264.48 to AmerisourceBergen Drug Corp for 90 capsules of Nexium DR 40 mg on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price, non-set-aside contract represents a pharmaceutical supply delivery to support federal medical procurement needs. The contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- This delivery order, awarded August 12, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 90-count supplies of Nexium DR 40 mg capsules with a ceiling value of $2.81K under firm fixed pricing. The award is non-competitive and represents a child contract under AmerisourceBergen's substantial $1 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,895.50 to AmerisourceBergen Drug Corp for the supply of Nexium DR 20 mg capsules (30-count units). The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Nexium DR 40 mg capsules (30-count packages) with a ceiling value of $2,250.24. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCHEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,687.56 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that functions as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a wide range of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Nexium, a proton pump inhibitor used to treat gastroesophageal reflux disease, represents a routine pharmaceutical supply fulfillment within the broader scope of the company's military healthcare supply operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/9/25 |